REVOLADE 25 MG POLVO PARA SUSPENSION ORAL
REVOLADE 25 MG POLVO PARA SUSPENSION ORAL
Commercialized
Register Number
110612013
Prescription Type
Uso Hospitalario
Authorization Date
May 17, 2016
Dosage Form
POLVO PARA SUSPENSIÓN ORAL
Route: VÍA ORAL
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number110612013
EMA Approved
Yes
Drug Classification
✗
Generic
No
✗
Orphan
No
✗
Biosimilar
No
✓
Commercialized
Yes
CIMA AEMPS Classification
INGREDIENTS (1)
ELTROMBOPAGActive
Quantity: 25 mg
Name: ELTROMBOPAG
ATC CLASSIFICATION (3)
B02B
B02BX
B02BX05